Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Irrimax Corporation | INDUSTRY |
Not provided
Not provided
Not provided
Study objectives include assessing the use of Irrisept irrigation solution in lumbar spinal fusion procedures and effect on clinical and patient reported outcome measures. This includes assessing postoperative SSI as well as fusion rates in addition to patient reported outcome measures.
This is a randomized controlled pilot study with a study size of 50 patients. Results will be utilized to plan a larger scale study. Background literature supports the use of chlorhexidine gluconate as an irrigation solution to decrease SSI although this has not been conducted in this population of patients (lumbar spine fusion) to date. A decrease in SSI with Irrisept, could support the possible use of this as an irrigation solution to decrease infections postoperatively. It will be important to know the effect if any of Irrisept on fusion rates. This study will provide valuable information that may assist in future treatment and prevention of SSI in lumbar spinal fusion patients.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| normal saline control arm | Placebo Comparator | ii. normal saline used after initial skin incision prior to coming through fascia, after placement of instrumentation (screws, hooks), prior to placement of bone graft, and after fascial closure iii. Irrigation exposure/soak time to be 1 min for each irrigation time point. |
|
| Irrisept irrigation solution | Active Comparator | ii. Irrigation (Irrisept vs control of normal saline) used after initial skin inicision prior to coming through fascia, after placement of instrumentation (screws, hooks), prior to placement of bone graft, and after fascial closure iii. Irrigation exposure/soak time to be 1 min for each irrigation time point. iv. 1 bottle (450 mL) Irrisept irrigation to be used during case with normal saline rinse to follow at each irrigation time point in study subjects |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Irrisept Irrigation solution | Device | ii. Irrigation (Irrisept vs control of normal saline) used after initial skin inicision prior to coming through fascia, after placement of instrumentation (screws, hooks), prior to placement of bone graft, and after fascial closure iii. Irrigation exposure/soak time to be 1 min for each irrigation time point. iv. 1 bottle (450 mL) Irrisept irrigation to be used during case with normal saline rinse to follow at each irrigation time point in study subjects v. Normal saline irrigation will be used alone in control subjects at the same time points. |
| Measure | Description | Time Frame |
|---|---|---|
| Postoperative surgical site infections | Postop SSI | assessed for change at 1 month |
| Postoperative surgical site infections | postop SSI | assessed for change at 3 months |
| Postoperative surgical site infections | postop SSI | assessed for change at 6 months |
| Postoperative surgical site infections | postop SSI | assessed for change at 12 months |
| Measure | Description | Time Frame |
|---|---|---|
| Fusion rates after surgery | fusion rates after surgery with irrisept vs saline irrigation | assessed at 1 month |
| Fusion rates after surgery | fusion rates after surgery with irrisept vs saline irrigation |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| The University of Kansas Medical Center | Kansas City | Kansas | 66106 | United States |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D013122 | Spinal Diseases |
| ID | Term |
|---|---|
| D001847 | Bone Diseases |
| D009140 | Musculoskeletal Diseases |
Not provided
Not provided
This is a randomized 1:1 treatment of placebo or standard of care irrigation and Irrisept solution.
Not provided
Not provided
Not provided
Not provided
|
| assessed for change at 3 months |
| Fusion rates after surgery | fusion rates after surgery with irrisept vs saline irrigation | assessed for change at 6 months |
| Fusion rates after surgery | fusion rates after surgery with irrisept vs saline irrigation | assessed for change at 12 months |
| Patient outcome measures | Visual Analog Score for pain measuring patient outcomes in both study arms | assessed at 1 month |
| Patient outcome measures | Visual Analog Score for pain measuring patient outcomes in both study arms | assessed at 3 months |
| Patient outcome measures | Visual Analog Score for pain measuring patient outcomes in both study arms | assessed at 6 months |
| Patient outcome measures | Visual Analog Score for pain measuring patient outcomes in both study arms | assessed at 12 months |
| Patient outcome measures | Oswestry Disability Index Questionnaire measuring patient outcomes in both study arms | assessed at 1 month |
| Patient outcome measures | Oswestry Disability Index Questionnaire measuring patient outcomes in both study arms | assessed at 3 months |
| Patient outcome measures | Oswestry Disability Index Questionnaire measuring patient outcomes in both study arms | assessed at 6 months |
| Patient outcome measures | Oswestry Disability Index Questionnaire measuring patient outcomes in both study arms | assessed at 12 months |
| Patient outcome measures | Scoliosis Research Society (SRS) 22 Questionnaire measuring patient outcomes in both study arms | assessed at 1 month |
| Patient outcome measures | Scoliosis Research Society (SRS) 22 Questionnaire measuring patient outcomes in both study arms | assessed at 3 months |
| Patient outcome measures | Scoliosis Research Society (SRS) 22 Questionnaire measuring patient outcomes in both study arms | assessed at 6 months |
| Patient outcome measures | Scoliosis Research Society (SRS) 22 Questionnaire measuring patient outcomes in both study arms | assessed at 12 months |